Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Hematologic Neoplasms × tafasitamab × 30 days × Clear all

Sponsor

Conditions

Recurrence 1 Lymphoma, Non-Hodgkin 1 Lymphoma, B-Cell 1 Lymphoma 1 Hodgkin Disease 1 Burkitt Lymphoma 1

Interventions

venetoclax 6 Specimen Handling 5 Cyclophosphamide 5 trametinib 4 fludarabine 4 Melphalan 3 Granulocyte Colony-Stimulating Factor 3 Biopsy 3 Azacitidine 3 talquetamab 2 pembrolizumab 2 fludarabine phosphate 2 dabrafenib 2 Whole-Body Irradiation 2 Thiotepa 2 Tacrolimus 2 Surveys and Questionnaires 2 Standard of Care 2 Sirolimus 2 Prednisone 2 Peripheral Blood Stem Cell Transplantation 2 Mycophenolic Acid 2 Methylprednisolone 2 Mesna 2 Health Promotion 2 Filgrastim 2 Cytarabine 2 trichostatin A 1 quizartinib 1 plerixafor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡